scispace - formally typeset
R

Ronald Bayer

Researcher at Columbia University

Publications -  184
Citations -  6970

Ronald Bayer is an academic researcher from Columbia University. The author has contributed to research in topics: Public health & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 42, co-authored 184 publications receiving 6600 citations. Previous affiliations of Ronald Bayer include Hastings Entertainment.

Papers
More filters
Book

Homosexuality and American Psychiatry: The Politics of Diagnosis

TL;DR: In 1973, after several years of bitter dispute, the Board of Trustees of the American Psychiatric Association decided to remove homosexuality from its official list of mental diseases, and a substantial number of dissident psychiatrists charged the association's leadership with capitulating to the pressures of Gay Liberation groups, and forced the board to submit its decision to a referendum of the full APA membership as discussed by the authors.
Journal ArticleDOI

Stigma and the ethics of public health: not can we but should we.

TL;DR: In the closing decades of the 20th century, a broadly shared view took hold that the stigmatization of those who were already vulnerable provided the context within which diseases spread, exacerbating morbidity and mortality.
Journal ArticleDOI

Public health policy and the AIDS epidemic. An end to HIV exceptionalism

TL;DR: In the early and mid-1980s, when democratic nations were forced to confront the public health challenge posed by the epidemic of the acquired immunodeficiency syndrome (AIDS), it was necessary to face a set of fundamental questions: Did the history of responses to lethal infectious diseases provide lessons about how best to contain the spread of human immunODeficiency virus (HIV) infection?
Journal ArticleDOI

The Renormalization of Smoking? E-Cigarettes and the Tobacco “Endgame”

TL;DR: Whereas some experts welcome e-cigarettes as a pathway to reducing tobacco use, others characterize them as dangerous products that could undermine efforts to denormalize smoking, the goal of eliminating the risks of smoking is not incompatible with e-cigarette use.